Expand your HIV Toolkit: Cabotegravir and Rilpivirine (CAB/RPV) Essentials and Clinical Guide

Publish date:

November 11, 2022

AETC Source

This resource is to inform healthcare providers about CAB/RPV, the first FDA-approved long-acting injectable antiretroviral (ARV) medication for patients with HIV. The comprehensive toolkit includes recommendations for patient evaluation, screening, and shared decision making when considering prescribing CAB/RPV. It also includes implementation tools such as sample checklists, protocols, and resources available to aid in the implementation of offering CAB/RVP in healthcare settings.

Toolkit

Browse more

Languages

English

Topic(s)

Antiretroviral Therapy

Type

Clinical Reference Tools

Quick survey

What is your primary profession/discipline

Other Non-Clinical Professional

Other Allied Professional

What is your primary functional role?

Specify Other Role

In what state or territory is your primary worksite?

To what extent have the resources and trainings available through this website increased your knowledge and skills to provide care for people with HIV?

Please indicate if you have used resources and/or trainings from any of the following in the past 12 months.

Select all that apply

Regional AETC Program(s)

National Clinician Consultation Center (NCCC)

National HIV Curriculum (NHC) e-Learning Platform Programs

I am not aware of any of these programs

Approximately what percentage of your patient visits are currently telehealth (phone or video) visits?